About
Derrick Li serves as Aardvark's Chief Business Officer and is a biotechnology executive with more than 20 years of global experience in biopharmaceutical business development, investment banking and corporate strategy. He previously served as Chief Strategy Officer at ODC Life Sciences and as Head of Strategy and Investor Relations at Cellular Biomedicine Group (now AbelZeta), and held investment banking roles including Managing Director in the Healthcare Investment Group at Robert W. Baird. Mr. Li earned a dual bachelor's degree in accountancy and finance from Villanova University.
Roles
Aardvark Therapeutics, Inc.
Chief Business Officer · Current role
Present
Aardvark Therapeutics, Inc.
Chief Business Officer
—
ODC Life Sciences
Chief Strategy Officer
—
Cellular Biomedicine Group (now AbelZeta)
Head of Strategy and Investor Relations
—
Robert W. Baird
Managing Director, Healthcare Investment Group
—
Also at Aardvark Therapeutics, Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.